Cargando…
Molecular diagnostics in the management of chronic hepatitis C: key considerations in the era of new antiviral therapies
Molecular tests that detect and/or quantify HCV RNA are important in the diagnosis and management of patients with chronic hepatitis C (CHC) undergoing anti-viral therapy. The primary goal of anti-HCV therapy is to achieve a sustained virologic response (SVR) defined as "undetectable" Hepa...
Autores principales: | Cobb, Bryan, Heilek, Gabrielle, Vilchez, Regis A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160902/ https://www.ncbi.nlm.nih.gov/pubmed/25236936 http://dx.doi.org/10.1186/1471-2334-14-S5-S8 |
Ejemplares similares
-
Strategies for treating and managing chronic hepatitis C in children in the direct-acting antiviral era
por: Hong, Suk-Jin, et al.
Publicado: (2020) -
Management of hepatitis C genotype 4 in the directly acting antivirals era
por: Hathorn, Emma, et al.
Publicado: (2016) -
Diagnostic and management considerations for “maskne” in the era of COVID-19
por: Teo, Wan-Lin
Publicado: (2021) -
New era for management of chronic hepatitis C virus using direct antiviral agents: A review
por: Elbaz, Tamer, et al.
Publicado: (2015) -
Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
por: Huang, Chung-Feng, et al.
Publicado: (2020)